A$0.004 0.0 14.3%
Last Trade - 09/04/21
| Market Cap | £7.84m |
| Enterprise Value | £8.10m |
| Revenue | £481k |
| Position in Universe | 1634th / 1893 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 30th Jun | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 1.12 | 2.12 | 1.25 | 1.01 | 0.83 | 0.81 | -6.3% | ||||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Analytica Limited is engaged in the design, development and supply of Class I and II medical devices. The Company's segments include Medical devices and Corporate. The Medical devices segment's products include PeriCoach (Perineometer), ELF-2 and AutoStart burette. The Company's lead product is the PeriCoach System, an e-health treatment system for women suffering from stress urinary incontinence. PeriCoach includes a device, Web portal and smartphone application. The device evaluates activity in pelvic floor muscles. The information is transmitted to a smartphone application and can be loaded to PeriCloud where physicians can monitor patient progress through Web portal. The Analytica Autostart Infusion System offers solution to regular monitoring and refilling of burettes in intravenous fluid infusion. The Autostart burette contains a float system that automatically restarts intra-venous (IV) fluid flow following infused delivery of the predetermined amount of a required medication.
| Last Annual | June 30th, 2020 |
| Last Interim | December 31st, 2020 |
| Incorporated | August 27, 1985 |
| Public Since | October 25, 2000 |
| No. of Shareholders: | n/a |
| No. of Employees: | 2 |
| Sector | Healthcare |
| Industry | Healthcare Equipment & Supplies |
| Index | |
| Exchange | Australian Stock Exchange - SEATS |
| Shares in Issue | 3,519,612,332 |
| Free Float | (0.0%) |
| Eligible for |
✓
ISAs
✓
SIPPs
|
| Address | 320 Adelaide St, BRISBANE, 4000, Australia |
| Web | http://www.analyticamedical.com/ |
| Phone | +61 7 32781950 |
| Contact | () |
| Auditors | Bentleys Brisbane (Audit) Pty Ltd |
As of 09/04/21, shares in Analytica are trading at A$0.004, giving the company a market capitalisation of £7.84m. This share price information is delayed by 15 minutes.
Shares in Analytica are currently trading at A$0.004 and the price has moved by 100% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Analytica price has moved by 50% over the past year.
There are no analysts currently covering Analytica.
Analytica is scheduled to issue upcoming financial results on the following dates:
Analytica does not currently pay a dividend.
Analytica does not currently pay a dividend.
Analytica does not currently pay a dividend.
To buy shares in Analytica you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Analytica are currently trading at A$0.004, giving the company a market capitalisation of £7.84m.
Here are the trading details for Analytica:
Based on an overall assessment of its quality, value and momentum, Analytica is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We were not able to load any forecast data for Analytica.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Analytica. Over the past six months, the relative strength of its shares against the market has been 16.62%. At the current price of A$0.004, shares in Analytica are trading at 35.14% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We were not able to find PE ratio data for Analytica.
Analytica's management team is headed by:
Here are the top five shareholders of Analytica based on the size of their shareholding:
